Vegetarian Diet and Innate Immunity in Patients With Myocardial Infarction and in Healthy Volunteers (FRESH-MI Study)

Last updated: January 15, 2024
Sponsor: Radboud University Medical Center
Overall Status: Active - Recruiting

Phase

N/A

Condition

Angina

Hypercholesterolemia

Cardiac Disease

Treatment

Vegetarian diet

Clinical Study ID

NCT06209723
NL84172.091.23
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The goal of this clinical trial is to assess the effect of a vegetarian diet on innate immunity of patients with a recent acute myocardial infarction and healthy participants. Also, we will assess the willingness to adapt a more vegetarian eating habit. Study subjects will follow a vegetarian diet for five weeks, whereafter a stabilisation period of six weeks will follow. Then, participants will follow to the other dietary intervention for five weeks. Blood will be drawn at given time points to analyse inflammatory parameters.

Eligibility Criteria

Inclusion

Inclusion Criteria for patients:

  • Acute myocardial infarction (STEMI/NSTEMI) with a clear culprit lesion on angiography and successful primary percutaneous coronary intervention (PCI) <1 week before randomisation

  • Body mass index between 18.5 and 35 kg/m2

  • Written informed consent

Inclusion Criteria for healthy volunteers (life partners / souses)

  • Body mass index between 18.5 and 35 kg/m2

  • Written informed consent

Exclusion Criteria for patients and healthy volunteers:

  • Already on a vegetarian or vegan diet

  • Previous myocardial infarction

  • Diabetes Mellitus

  • Medical history of any disease associated with immune deficiency (either congenital or acquired, including chemotherapy, chronic steroid use, organ transplant)

  • Use of immunomodulatory drugs

  • Vaccination less than one month before start of intervention

  • Clinically significant infections within 1 months prior to start of intervention (defined as fever >38.5 degrees Celsius)

  • Active malignant haematological disease

  • Known eating disorder (e.g., Anorexia nervosa, Bulimia nervosa)

Exclusion Criteria for healthy volunteers

  • Use of lipid lowering therapy

Study Design

Total Participants: 120
Treatment Group(s): 1
Primary Treatment: Vegetarian diet
Phase:
Study Start date:
January 08, 2024
Estimated Completion Date:
September 01, 2026

Study Description

We will perform a proof-of-concept study according to a prospective randomized open label blinded endpoint (PROBE) design. Patients with an acute myocardial infarction (AMI) and their healthy life partners / spouses will be randomly assigned to an immediate vegetarian diet or their habitual diet. Patients with AMI will be stratified for non-ST-elevation myocardial infarction (NSTEMI) or ST-elevation myocardial infarction (STEMI). The dietary intervention will start one week after the index event and will comprise a period of five weeks. After a stabilisation phase (six weeks), to assure normalisation of the inflammatory response secondary to the acute myocardial infarction, patients and their spouses will follow the other dietary intervention arm. Then, half of them will start directly with the other dietary intervention and half of them will start after a period of five weeks. Blood samples will be taken at the time points. Also, all participants will be asked to complete a questionnaire at baseline, after twelve weeks and at nine months follow-up. Infarct size as assessed by Cardiovascular Magnetic Resonance (CMR) imaging will be used to adjust cytokine levels.

Connect with a study center

  • Radboudumc

    Nijmegen,
    Netherlands

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.